I am a board-certified radiation oncologist with a wide range of interests and expertise. Before joining the Memorial Sloan Kettering faculty, I served as chief resident as New York University School of Medicine. My research and clinical interest is in using technology to allow for more-targeted radiotherapy in order to minimize toxicity to normal tissues while maintaining appropriate therapy to the primary tumor.
I have been extensively involved in studying the effects of positioning (supine or prone) in minimizing the exposure of the heart and lungs to radiation during treatment for breast cancer. I have also looked at the use of different techniques for delivery of intensity-modulated radiation therapy (IMRT) to different disease sites. For example, in brain tumors (both malignant and benign) we use these techniques to minimize damage to normal tissues such as the temporal lobe in order to avoid or minimize the possible cognitive effects of radiation.
I have extensive experience in image-guided radiotherapy (IGRT) using Cone Beam CT and in the use of MV and KV imaging for more-targeted therapy. I have experience in stereotactic therapy including brain and body stereotactic surgery, body radiotherapy, and treatment using respiratory gating techniques and 4D-CT techniques.
One of the unique advantages of Memorial Sloan Kettering is our close relationship with faculty in all the specialties and throughout the regional sites and main campus. This collaboration allows us to have a truly multi-disciplinary approach to the management of our patients and allows our patients to receive the best care possible.
- Clinical Expertise: Radiation Therapy for Cancers of the Breast, Central Nervous System, Prostate, Head and Neck; Image-Guided Radiotherapy (IGRT); Brain Radiosurgery
- Languages Spoken: English
- Education: MD, New York University School of Medicine; MPH Columbia University
- Residencies: Lenox Hill Hospital; New York University School of Medicine
- Board Certifications: Radiation Oncology
Research is integral to our mission at Memorial Sloan Kettering, and clinical trials help us discover better forms of patient care and treatment. For you, this could mean access to a new therapy or therapy combination. Click to see a list of the trials I’m currently leading.
Clinical Trials Co-Investigated by Preeti K. Parhar
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more